Unlikely new anti-cancer target
Tuesday, August 13, 2013 - 02:00
in Health & Medicine
Interleukin-11 could be the 'dark horse' in cancer development and a new target for stomach and bower cancer drugs, research suggests.
Interleukin-11 could be the 'dark horse' in cancer development and a new target for stomach and bower cancer drugs, research suggests.